Home » Topics » Regulatory

Regulatory
RSS

New approval for Eloxatin

Nov. 9, 2004

New indication for Sandostatin injection approved in Japan

Oct. 29, 2004

European approval for Emselex

Oct. 28, 2004

CHMP adopts extension of indication for Schering-Plough HCV products

Oct. 27, 2004

Lundbeck files for new Alzheimer's indication for Ebixa in Europe

Oct. 25, 2004

Remicade receives European approval for psoriatic arthritis

Oct. 19, 2004

Approval for new Cancidas indication

Oct. 15, 2004

European approval for Protelos

Oct. 6, 2004

Abilify approved for acute bipolar mania

Oct. 5, 2004

FDA approves Remicade as first-line therapy in moderate to severe RA

Oct. 5, 2004

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...